Market revenue in 2023 | USD 152.6 million |
Market revenue in 2030 | USD 210.5 million |
Growth rate | 4.7% (CAGR from 2023 to 2030) |
Largest segment | Topical |
Fastest growing segment | Topical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oral, Topical |
Key market players worldwide | GSK PLC, Abbott Laboratories, Pfizer Inc, Bausch Health Companies Inc, Bayer AG, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Merck & Co Inc, Novartis AG ADR, Sun Pharmaceutical Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to onychomycosis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 57.67% in 2023. Horizon Databook has segmented the Canada onychomycosis market based on oral, topical covering the revenue growth of each sub-segment from 2018 to 2030.
The growing geriatric and diabetic population and the increase in approvals of onychomycosis drugs in Canada are some of the key factors anticipated to boost the demand for onychomycosis products.
According to an article published by Diabetes Canada in March 2022, more than 5.7 million individuals living in Canada have diabetes. In addition, over 11.7 million Canadians are prediabetic.
Furthermore, individuals with diabetes are more likely to get infected with onychomycosis than those without diabetes. Thus, the incidence of onychomycosis in Canada is expected to grow due to the rising prevalence of diabetes across the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada onychomycosis market , including forecasts for subscribers. This country databook contains high-level insights into Canada onychomycosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account